- Advertise
- About OncLive
- Editorial Board
- MJH Life Sciences brands
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2025 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Latest Conference Articles
The OncLive® Conference page includes a listing of all conferences covered by OncLive®, including the ASCO, ESMO, SITC, EHA, ASH, and SABCS annual meetings, as well as the Chemotherapy Foundation Symposium and Miami Breast Cancer Conference, among many others. Conference coverage incorporates articles and interviews in written and video format.
Coverage From the 2012 NCONN Conference
September 23rd 2012, 2:03pm
OncLive presents live coverage from the 2012 NCONN Changing the Face of Cancer Care Conference, held at the Gaylord Opryland Hotel from October 4th to 6th, in Nashville, TN.
Dr. Haugen Describes the 82nd Annual ATA Meeting
September 21st 2012, 2:35pm
Annual Meeting of the American Thyroid Association
Dr. Bryan Haugen, from University of Colorado School of Medicine, Describes the 82nd Annual Meeting of the American Thyroid Association.
Dr. Nikiforov on Molecular Testing of Thyroid Nodules
September 21st 2012, 2:21pm
Annual Meeting of the American Thyroid Association
Dr. Yuri Nikiforov, from the University of Pittsburgh, on Molecular Testing to Diagnose Cancerous Thyroid Nodules.
Blanket Approach to RAI in PTC Patients May Not Be Necessary
September 21st 2012, 12:56pm
Annual Meeting of the American Thyroid Association
A blanket approach to the use of radioactive iodine may not be necessary in many patients with papillary thyroid cancer provided they undergo expert total thyroidectomy first.
Disease Stabilization Now Possible in Metastatic MTC With Targeted Therapies
September 21st 2012, 12:00pm
Annual Meeting of the American Thyroid Association
The availability of molecular agents that target oncogenic signaling pathways now offers the possibility of achieving disease stabilization in a proportion of patients with metastatic medullary thyroid cancer.
Initial Operation to Remove Medullary Thyroid Cancer Best Chance for Cure
September 21st 2012, 9:03am
Annual Meeting of the American Thyroid Association
The initial surgical procedure performed for the management of medullary thyroid cancer is the best chance surgeons have for a cure.
Conference Coverage From the 2012 ESMO Congress
September 20th 2012, 12:12pm
Coverage from the 2012 European Society for Medical Oncology congress, held at the Austria Center Vienna from September 28 - October 2, in Vienna, Austria.
Dr. Spigel Discusses the Evolving NSCLC Treatment Landscape
September 14th 2012, 2:10pm
Chicago Multidisciplinary Symposium in Thoracic Oncology
Dr. David Spigel, from the Sarah Cannon Research Institute, discusses the rapidly evolving non-small cell lung cancer treatment landscape.
Dr. Reckamp Evaluates the Predictive Efficacy of VeriStrat
September 14th 2012, 10:57am
Chicago Multidisciplinary Symposium in Thoracic Oncology
Dr. Karen Reckamp, from City of Hope, evaluates the predictive efficacy of the pretreatment serum test VeriStrat for non-small cell lung cancer.
Targeted Therapy Combination Slows NSCLC
September 14th 2012, 8:30am
Chicago Multidisciplinary Symposium in Thoracic Oncology
Patients with refractory non-small cell lung cancer had a statistically significant improvement in PFS when treated with targeted therapy duo versus a single agent.
Mutation Confers Anti-EGFR Resistance
September 14th 2012, 6:13am
Chicago Multidisciplinary Symposium in Thoracic Oncology
A common mutation in NSCLC confers resistance to tyrosine kinase inhibitors and worsens survival, creating a need for an alternative approach to treating the subgroup of patients with the mutation.
Hint of Survival Benefit in NSCLC With Bavituximab Plus Docetaxel
September 13th 2012, 1:57pm
Chicago Multidisciplinary Symposium in Thoracic Oncology
Patients with advanced non-small cell lung cancer lived twice as long when they received an indirect angiogenesis inhibitor plus docetaxel instead of docetaxel alone.
The 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology
September 8th 2012, 2:37pm
Chicago Multidisciplinary Symposium in Thoracic Oncology
A brief introduction to the topics and focus of the 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology.
Dr. Crawford on Managing Febrile Neutropenia
July 2nd 2012, 9:11am
Multinational Association of Supportive Care in Cancer International Symposium
Jeffrey Crawford, MD, from Duke University Medical Center, on Managing Febrile Neutropenia.
Photos From the 2012 MASCC/ISOO Symposium
July 2nd 2012, 8:51am
Multinational Association of Supportive Care in Cancer International Symposium
A compilation of photos from the 2012 combined conferences of the Multinational Association of Supportive Care in Cancer (MASCC) and the International Society of Oral Oncology (ISOO).
Dr. Holland on the Stigma Toward Psychosocial Care
June 30th 2012, 2:34pm
Multinational Association of Supportive Care in Cancer International Symposium
Dr. Jimmie Holland, from Memorial Sloan-Kettering Cancer Center, on the Stigma Toward Psychosocial Care.
Diarrhea Less Severe With Molecularly Targeted Agents Than With Standard Chemotherapy
June 30th 2012, 7:09am
Multinational Association of Supportive Care in Cancer International Symposium
Recent evidence shows that some of the newer molecularly targeted therapies can cause diarrhea, which can lead to dose reductions and alterations.
Targeted Therapies Safer for Heart Than Anthracyclines
June 30th 2012, 6:42am
Multinational Association of Supportive Care in Cancer International Symposium
Although molecularly targeted agents can cause cardiac damage, it appears to be reversible and related to cellular dysfunction, as distinct from agents such as anthracyclines that cause cellular death and irreversible cardiac dysfunction.
Dr. Gralla on Chemotherapy-Induced Nausea and Vomiting
June 30th 2012, 6:17am
Multinational Association of Supportive Care in Cancer International Symposium
Dr. Richard Gralla, from the Quality of Life Research Associates, on Chemotherapy-Induced Nausea and Vomiting.
Dr. Foley Discusses Guidelines for Cancer Pain Management
June 29th 2012, 7:42am
Multinational Association of Supportive Care in Cancer International Symposium
Dr. Kathleen Foley, from Memorial Sloan-Kettering Cancer Center, Discusses the World Health Organization Guidelines for Cancer Pain Management.